SEC Filing Update: #PCVX Vaxcyte, Inc. : $63.17

Sector: Healthcare | YTD: 🔼+ 35.91% The SEC disclosed Today (06-NOV-2026) that T. Rowe Price Investment Management, Inc. has INCREASED #PCVX Shares by 17.24% 🟢 * Previous Holdings: 12.21M Shares * Current Holdings: 14.31M Shares * Increase+2.10M * Increased(%)+17.24% * Ownership: 9.6% * Estimated Investment Value: $130.27M https://www.thinksabio.com/reports/isr/PCVX The quarterly average prices of #PCVX: Q3 2025: $33.12 Q4 2025: $44.70 Q1 2026: $54.29 Q2 2026: $54.30 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2118737356412850646